新型分子标用于肝细胞癌的免疫监测
Pietro Guerra1, Andrea Martini1, Patrizia Pontisso1
1Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine (DIMED), University of Padova, 35122 Padova, Italy.
Cancers
|July 29, 2023
概括
肝细胞癌 (HCC) 免疫疗法由于其复杂的瘤微环境 (TME) 而显示出有限的疗效. 了解HCC TME内的免疫细胞相互作用是开发有效治疗方法和确定新的治疗点的关键.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 癌症免疫学 癌症免疫学
- 瘤微环境 (TME) 研究研究.
背景情况:
- 肝细胞癌 (HCC) 是一种具有越来越高的发病率和高死亡率的侵袭性癌症.
- 目前针对HCC的免疫疗法有效性有限,需要对瘤微环境 (TME) 进行更深入的了解.
- 构成多种免疫和层状细胞的TME显著影响HCC的进展和治疗反应.
研究的目的:
- 审查了解HCC TME的最新进展.
- 为了识别HCC.中参与抗瘤反应的关键免疫细胞.
- 探索HCC免疫治疗的新型治疗点.
主要方法:
- 关于HCC TME和免疫治疗的最近研究的文献综述.
- 分析免疫细胞透和功能在HCC.
- 研究潜在的治疗点,包括SerpinB3.
主要成果:
- HCC TME是一个复杂的生态系统,影响治疗结果.
- 特定的免疫细胞种群及其相互作用对于抗瘤免疫非常重要.
- 塞尔宾B3在各种癌症中起到免疫反应调节的作用,包括潜在的HCC.
结论:
- 对HCC TME的全面理解对于改善免疫疗法至关重要.
- 向特定的免疫细胞和通路,如SerpinB3,可能会提高HCC治疗效率.
- 基于免疫透的HCC分类可以指导个性化治疗策略.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
Cytotoxic T Cells-mediated Immune Response
972
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
972
Immune Surveillance by NK Cells and Phagocytes
1.5K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.5K


